Our more recent works showed that a nanoparticle-mediated plasmid encoding HGFK1 gene (H1/pHGFK1) exerts anti-tumor and radiosensitive activities through inhibiting MET signaling pathway, an important cancer cells “stemness” regulator in glioblastoma [10, 24]. The gene discussed is MET; the disease is cancer.